UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 773

Sortiert nach

A tale of two receptors: insulin and insulin-like growth factor signaling in cancer

Clinical cancer research, 2015-02, Vol.21 (4), p.667-669

Yee, Douglas

2015

Link zum Volltext

Verfügbarkeit prüfen

Disrupting Insulin and IGF Receptor Function in Cancer

International journal of molecular sciences, 2021-01, Vol.22 (2), p.555

2021

Link zum Volltext

Verfügbarkeit prüfen

Disrupting insulin-like growth factor signaling as a potential cancer therapy

Molecular cancer therapeutics, 2007-01, Vol.6 (1), p.1-12

2007

Link zum Volltext

Verfügbarkeit prüfen

IGF-I Regulates Redox Status in Breast Cancer Cells by Activating the Amino Acid Transport Molecule xC

Cancer research (Chicago, Ill.), 2014-04, Vol.74 (8), p.2295-2305

2014

Link zum Volltext

Verfügbarkeit prüfen

Killing the second messenger: targeting loss of cell cycle control in endocrine-resistant breast cancer

Endocrine-related cancer, 2011-08, Vol.18 (4), p.C19-C24

2011

Link zum Volltext

Verfügbarkeit prüfen

Revisiting the IGF-1R as a breast cancer target

NPJ precision oncology, 2017-05, Vol.1 (1), p.1-7, Article 14

2017

Link zum Volltext

Verfügbarkeit prüfen

APOBEC3B is an enzymatic source of mutation in breast cancer

Nature (London), 2013-02, Vol.494 (7437), p.366-370

2013

Link zum Volltext

Verfügbarkeit prüfen

Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives

Nanomedicine (London, England), 2008-02, Vol.3 (1), p.83

2008

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment

Breast cancer research : BCR, 2018-10, Vol.20 (1), p.115-115, Article 115

2018

Link zum Volltext

Verfügbarkeit prüfen

Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins

The Journal of clinical investigation, 2008-07, Vol.118 (7), p.2609-2619

2008

Link zum Volltext

Verfügbarkeit prüfen

Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysis

Breast cancer (Tokyo, Japan), 2021-05, Vol.28 (3), p.618-629

2021

Link zum Volltext

Verfügbarkeit prüfen

Randomized Controlled Trial of Weight Training and Lymphedema in Breast Cancer Survivors

Journal of clinical oncology, 2006-06, Vol.24 (18), p.2765-2772

2006

Link zum Volltext

Verfügbarkeit prüfen

40 YEARS OF IGF1: Anti-insulin-like growth factor therapy in breast cancer

Journal of molecular endocrinology, 2018-07, Vol.61 (1), p.T61-T68

Yee, Douglas

2018

Link zum Volltext

Verfügbarkeit prüfen

IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas

PloS one, 2015-07, Vol.10 (7), p.e0133152-e0133152

2015

Link zum Volltext

Verfügbarkeit prüfen

Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer

PLoS genetics, 2023-11, Vol.19 (11), p.e1011043-e1011043

2023

Link zum Volltext

Verfügbarkeit prüfen

Anti-Insulin-like Growth Factor Therapy in Breast Cancer

Journal of molecular endocrinology, 2018-07, Vol.61 (1), p.T61-T68

Yee, Douglas

2018

Link zum Volltext

Verfügbarkeit prüfen

Water-fat MRI for assessing changes in bone marrow composition due to radiation and chemotherapy in gynecologic cancer patients

Journal of magnetic resonance imaging, 2013-12, Vol.38 (6), p.1578-1584

2013

Link zum Volltext

Verfügbarkeit prüfen

Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin

Cancer research (Chicago, Ill.), 2007, Vol.67 (1), p.391-397

2007

Link zum Volltext

Verfügbarkeit prüfen

The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer

Science advances, 2016-10, Vol.2 (10), p.e1601737

2016

Link zum Volltext

Verfügbarkeit prüfen

Type I insulin-like growth factor receptor as a therapeutic target in cancer

Cancer research (Chicago, Ill.), 2005-11, Vol.65 (22), p.10123-10127

2005

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor

Breast cancer research and treatment, 2012-05, Vol.133 (1), p.117-126

2012

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of Weight Training in Recent Breast Cancer Survivors to Alter Body Composition, Insulin, and Insulin-Like Growth Factor Axis Proteins

Cancer epidemiology, biomarkers & prevention, 2005-07, Vol.14 (7), p.1672-1680

2005

Link zum Volltext

Verfügbarkeit prüfen

Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes

Frontiers in oncology, 2023-06, Vol.13, p.1192208-1192208

2023

Link zum Volltext

Verfügbarkeit prüfen

Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor : Implications for anti-insulin-like growth factor therapy in breast cancer

Cancer research (Chicago, Ill.), 2006-02, Vol.66 (4), p.2391-2402

2006

Link zum Volltext

Verfügbarkeit prüfen

The Emerging Role of the Fetal Insulin Receptor in Hormone-refractory Breast Cancer

Endocrinology (Philadelphia), 2021-10, Vol.162 (10), p.1

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 773

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(718)
Mit Volltextzugriff
(706)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

A tale of two receptors: insulin and insulin-like growth factor signaling in cancer

Disrupting Insulin and IGF Receptor Function in Cancer

Disrupting insulin-like growth factor signaling as a potential cancer therapy

IGF-I Regulates Redox Status in Breast Cancer Cells by Activating the Amino Acid Transport Molecule xC

Killing the second messenger: targeting loss of cell cycle control in endocrine-resistant breast cancer

Revisiting the IGF-1R as a breast cancer target

APOBEC3B is an enzymatic source of mutation in breast cancer

Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives

Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment

Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins

Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysis

Randomized Controlled Trial of Weight Training and Lymphedema in Breast Cancer Survivors

40 YEARS OF IGF1: Anti-insulin-like growth factor therapy in breast cancer

IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas

Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer

Anti-Insulin-like Growth Factor Therapy in Breast Cancer

Water-fat MRI for assessing changes in bone marrow composition due to radiation and chemotherapy in gynecologic cancer patients

Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin

The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer

Type I insulin-like growth factor receptor as a therapeutic target in cancer

Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor

Safety and Efficacy of Weight Training in Recent Breast Cancer Survivors to Alter Body Composition, Insulin, and Insulin-Like Growth Factor Axis Proteins

Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes

Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor : Implications for anti-insulin-like growth factor therapy in breast cancer

The Emerging Role of the Fetal Insulin Receptor in Hormone-refractory Breast Cancer

Suchergebnisse filtern